Metraipolis › archive › dc_07cb263d5fbf
Optimizing antiphospholipid antibody testing: a real-world analysis of appropriateness and resource utilization — Europe PMC PMID:40958002
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40958002
- DOI
- 10.1007/s12026-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:22:23.027Z
- SHA-256 of the archived text
80cc8476ee1f8b1c8dfaf72405c7f9176266a709364e75afa3cc9b30a7e3967c- Stable URL of this page
https://metraipolis.com/documento/dc_07cb263d5fbf
How to cite
Optimizing antiphospholipid antibody testing: a real-world analysis of appropriateness and resource utilization — Europe PMC PMID:40958002 — Europe PMC (en), https://europepmc.org/article/MED/40958002 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07cb263d5fbf (Metraipolis archive dc_07cb263d5fbf, sha256 80cc8476ee1f8b1c8dfaf72405c7f9176266a709364e75afa3cc9b30a7e3967c)
BibTeX
@misc{dc07cb263d5fbf,
title = {Optimizing antiphospholipid antibody testing: a real-world analysis of appropriateness and resource utilization — Europe PMC PMID:40958002},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40958002},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07cb263d5fbf; sha256 80cc8476ee1f8b1c8dfaf72405c7f9176266a709364e75afa3cc9b30a7e3967c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40958002. Agents can read the archived copy with the MCP tool read_document.